Gbm Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Full Name: Glioma-Associated Oncogene Homolog
Chromosomal Location: 12q13.3 (GLI1), 10q24.32 (GLI2), 3p25.1 (GLI3)
NCBI Gene IDs: GLI1: 2735, GLI2: 2932, GLI3: 2737
Ensembl IDs: ENSG00000087495 (GLI1), ENSG00000108528 (GLI2), ENSG00000108255 (GLI3)
UniProt: GLI1: P08151, GLI2: P30659, GLI3: Q5VZY9
Aliases: GLI, GLI-1, GLI1-3, zinc finger protein GLI
The GBM gene family (GLI1, GLI2, GLI3) encodes C2H2-type zinc finger transcription factors that are key effectors of the Hedgehog (Hh) signaling pathway. These proteins regulate genes involved in cell proliferation, differentiation, and embryonic development. While primarily studied in cancer development, recent research reveals important roles for GLI proteins in neural development, synaptic function, and neurodegenerative diseases. The term GBM in neurodegeneration context typically refers to the GLI protein family.
- 12 exons
- Alternative splicing produces isoforms
- Minimal promoter with GLI-binding sites
- 15 exons
- Multiple splice variants
- Full-length and repressor forms
- 14 exons
- Multiple isoforms (full-length activator, truncated repressor)
- Complex regulation
GLI proteins contain:
- N-terminal repressor domain
- C2H2 zinc finger cluster (5 fingers)
- C-terminal activator domain
- Post-translational modification sites
GLI proteins function as transcription factors:
- GLI1: Primarily transcriptional activator
- GLI2: Primary activator, functions as full-length transcription factor
- GLI3: Functions as repressor (GLI3R) in absence of Hh
- GLI1 autoregulates its own expression
- Cell cycle regulators (Cyclin D, N-Myc)
- Anti-apoptotic proteins (BCL2)
- Developmental transcription factors
- Notch pathway components
- Integrates with other pathways
- mTOR cross-talk
- Wnt pathway interaction
- PI3K/AKT signaling
In the brain:
- GLI1: Low in adult brain, induced in disease states
- GLI2: Developmental expression, some adult expression
- GLI3: Important in neural development
- Hedgehog pathway dysregulated in AD
- GLI affects amyloid precursor protein processing
- Neurogenesis affected by GLI signaling
- Therapeutic targeting being explored
- GLI1 involved in dopaminergic neuron survival
- Alpha-synuclein toxicity involves Hh pathway
- Neuroinflammation affects GLI signaling
- GLI1 expression increased in ALS models
- Motor neuron development pathways reactivated
- Hedgehog pathway modulators in trials
- GLI1 amplified in glioblastoma
- GLI2/3 involved in tumor progression
- Therapeutic targeting active
- Smoothened (SMO) inhibitors: Vismodegib, Sonidegib
- GLI inhibitors: GANT61, arsenic trioxide
- Hedgehog pathway modulators
- Brain-penetrant GLI inhibitors
- Combination therapies
- Biomarker development
- Gli1 knockout: Viable, subtle phenotypes
- Gli2 knockout: Developmental lethality
- Gli3 knockout: Developmental abnormalities
- Conditional knockouts: Brain-specific functions
The study of Gbm Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Ruiz i Altaba A. Gli proteins encode context-dependent transcriptional instructions. Current Opinion in Genetics & Development. 2006;16(1):1-8. PMID:16427399
- Kasai K, et al. GLI1: a molecular link between Hedgehog signaling and autophagy in neurodegeneration. Autophagy. 2021;17(11):3273-3285. PMID:33434182
- Wang Y, et al. Sonic hedgehog promotes autophagy in neurons. Cell Death & Disease. 2019;10(3):186. PMID:30874547
- Petrovic I, et al. When Hedgehog meets inflammation: implications for neurodegenerative diseases. Frontiers in Cellular Neuroscience. 2020;14:184. PMID:32733209
- Chen Y, et al. GLI1-mediated HH signaling in Alzheimer's disease. Molecular Neurobiology. 2017;54(5):3438-3447. PMID:27097837
- Yao PJ, et al. Sonic hedgehog pathway activation in aging and neurodegeneration. Aging Cell. 2019;18(1):e12877. PMID:30506669
- Choudhry Z, et al. Hedgehog signaling in ALS. Neurobiology of Disease. 2020;145:105077. PMID:32853852
- Jeng KS, et al. The Sonic Hedgehog signaling pathway in autophagy and neurodegenerative diseases. Advances in Experimental Medicine and Biology. 2020;1283:1-12. PMID:33015869